Expert Opinion on Drug Metabolism and Toxicology
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Expert Opinion on Drug Metabolism & Toxicology is a monthly peer-reviewed medical journal publishing review articles on ADME-Tox. It was established in 2005 and is published by Taylor and Francis. The editor-in-chief is Luis Valerio (Food and Drug Administration). Less
Key Metrics
View Chart Journal Specifications
- PublisherTAYLOR & FRANCIS LTD
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year2005
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 34% |
| 4-6 | 56% |
| 7-9 | 10% |
| >9 | 0% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Expert Opinion on Drug Metabolism and Toxicology been publishing? 
The Expert Opinion on Drug Metabolism and Toxicology has been publishing since 2005 till date.
How frequently is the Expert Opinion on Drug Metabolism and Toxicology published?
Expert Opinion on Drug Metabolism and Toxicology is published Monthly.
Who is the publisher of Expert Opinion on Drug Metabolism and Toxicology?
The publisher of Expert Opinion on Drug Metabolism and Toxicology is TAYLOR & FRANCIS LTD.
Where can I find a journal's aims and scope of Expert Opinion on Drug Metabolism and Toxicology?
For the Expert Opinion on Drug Metabolism and Toxicology's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Expert Opinion on Drug Metabolism and Toxicology on editage?
For the Expert Opinion on Drug Metabolism and Toxicology metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Expert Opinion on Drug Metabolism and Toxicology?
The eISSN number is 1744-7607 and pISSN number is 1742-5255 for Expert Opinion on Drug Metabolism and Toxicology.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Toxicity, Erythropoietin, Allele, Pharmacogenomics, Drug transport, Cytochrome P450, Neurotoxicity, Arylamine N-acetyltransferase, Adjuvant therapy, Methotrexate, Peripheral neuropathy, Clinical trial, Therapeutic drug monitoring, N-acetyltransferase, Inositol, ATP-binding cassette transporter, Lung, Oral administration, Metabolic enzymes, Bioavailability.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.